HLA
HSTO

Hamilton Lane Advisors’s Histogen Inc. Common Stock HSTO Stock Holding History

Hamilton Lane Advisors’s Portfolio HSTO Stock Details HSTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-166
Closed -$232K – 65
2014
Q4 		$232K Hold
166
– – 0.09% 49
2014
Q3 		$203K Hold
166
– – 0.07% 51
2014
Q2 		$302K Hold
166
– – 0.09% 51
2014
Q1 		$270K Buy
+166
New +$347K 0.11% 59

Other funds holding HSTO

MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return

Hamilton Lane Advisors's HSTO Position: Q1 2015 in Review

Hamilton Lane Advisors sold out of Histogen Inc. Common Stock (HSTO) in Q1 2015, closing a stake of 166 shares — an estimated $232K sold.

Hamilton Lane Advisors first reported a position in HSTO in Q1 2014 and held it in 4 quarters. The position peaked at $302K in Q2 2014. 32 funds tracked by Wall St. Rank hold HSTO as of Q1 2015.

  • Hamilton Lane Advisors reported no remaining Histogen Inc. Common Stock position as of Q1 2015 after selling out during the quarter.
  • Hamilton Lane Advisors sold 166 Histogen Inc. Common Stock shares in Q1 2015, an estimated $232K.
  • Hamilton Lane Advisors first reported a position in Histogen Inc. Common Stock in Q1 2014 and held it in 4 quarters.
  • Hamilton Lane Advisors's Histogen Inc. Common Stock position peaked at $302K in Q2 2014.
  • 32 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q1 2015.

Based on Hamilton Lane Advisors's 13F filing for Q1 2015, filed 8 Apr 2015.